Inventor profile of:

David S. Terman

City:

Pebble Beach, California

Country:

United States

Published Applications:

19

Last publication date:

2021-03-11

Top Assignees for applications by David S. Terman

The entities that hold a legal rights for patent applications filed by inventor Terman David S.:

Recent patent applications by Terman David S.

David S. Terman from Pebble Beach, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-03-11
US20210069314A1
Human necessities

Compositions and Methods for Treatment of Cancer

#2 | 2020-09-24
US20200297658A1
Human necessities

Compositions and methods for treatment of cancer

#3 | 2018-02-01
US20180028639A1
Human necessities

Compositions and methods for treatment of cancer

#4 | 2016-05-26
US20160144002A1
Human necessities

Sickled Erythrocytes and Progenitors Target Cytotoxics to Tumors

#5 | 2016-03-03
US20160058793A1
Human necessities

Tumor Targeted Sickle Erythroid Precursors, Progenitors and Hematopoietic Stem Cells, Induced Pluripotent Stem Cells, Microparticles and Liposomes for Treatment of Cancer

#6 | 2015-02-05
US20150037297A1
Human necessities

Sickled Erythrocytes and Progenitors Target Cytotoxics to Tumors

#7 | 2014-07-24
US20140205617A1
Human necessities

Compositions and Methods for Treatment of Neoplastic Disease

#8 | 2014-03-27
US20140088020A1
Human necessities

Composition and Methods for Treatment of Cancer

#9 | 2013-01-24
US20130021346A1
Physics

Knowledge acquisition nexus for facilitating concept capture and promoting time on task

#10 | 2012-08-02
US20120195869A1
Human necessities

Sickled erythrocytes with anti-tumor agents induce tumor vaso-occlusion and tumoricidal effects

#11 | 2012-06-14
US20120148628A1
Human necessities

Compositions and methods for treatment of cancer

#12 | 2011-03-10
US20110059901A1
Chemistry; metallurgy

Compositions and Methods for Treatment of Neoplastic Disease

#13 | 2010-08-12
US20100203024A1
Human necessities

Sickled Erythrocytes, Nucleated Precursors & Erythroleukemia Cells for Targeted Delivery of Oncolytic Viruses, Anti-tumor Proteins, Plasmids, Toxins, Hemolysins & Chemotherapy

#14 | 2010-08-05
US20100196373A1
Human necessities

Intrathecal and intratumoral superantigens to treat malignant disease

#15 | 2009-06-25
US20090162315A1
Human necessities

Enterotoxin gene cluster (egc) superantigens to treat malignant disease

#16 | 2009-06-18
US20090155231A1
Chemistry; metallurgy

Compositions and methods for treatment of neoplastic disease

#17 | 2009-05-14
US20090123444A1
Human necessities

Compositions and methods for treatment of neoplastic disease

#18 | 2006-03-09
US20060052295A1
Human necessities

Intrathecal and intratumoral superantigens to treat malignant disease

#19 | 2005-05-26
US20050112141A1
Chemistry; metallurgy

Compositions and methods for treatment of neoplastic disease

InventorID:

49776 ⎘